Dr. Joel Benjamin Freid, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 5925 Imperial Pkwy, Suite 128, Mulberry, FL 33860 Phone: 863-644-0506 Fax: 863-644-7522 |
News Archive
Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.
In a recent open-access paper published in the Journal of Clinical Medicine, researchers from Iran and Germany show that high baseline levels of inflammatory cytokines measured during admission put patients with coronavirus disease (COVID-19) at increased risk of developing coagulopathy, thrombotic events – and even death.
InterMune, Inc. today announced that it has reached a definitive agreement with Vidara Therapeutics International Limited (Vidara) to sell its rights to Actimmune (interferon gamma-1b) in a cash transaction valued at $55 million plus a two-year royalty stream.
POZ in its November issue examined HIV/AIDS in the U.S. South. The South - which includes 14 states and Washington, D.C. - accounts for 45% of new U.S. HIV cases and 50% of all AIDS-related deaths, according to CDC. Seven of the 10 states with the highest AIDS rates also are located in the South, and an increasing number of people living with the disease reside in the region.
SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products focused on the treatment of pain, announced today that it has completed patient enrollment for the dermal safety studies and the pivotal pharmacokinetic study related to its investigational product Ztlido (lidocaine patch 1.8%), a next-generation branded lidocaine patch for the treatment of postherpetic neuralgia, also referred to as "after-shingles pain."
› Verified 7 days ago